Related Experiment Video
Updated: Jan 26, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Smart Drug Release from Medical Devices
Carmen Alvarez-Lorenzo1, Angel Concheiro2
1Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+DPharma Group (GI-1645), Facultad de Farmacia, and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Smart medical devices can actively regulate drug release in response to environmental cues, improving therapeutic outcomes and enabling personalized medicine. These advanced drug-eluting devices offer on-demand delivery, minimizing risks and side effects for better patient care.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Medical devices are crucial for health monitoring and treatment, with advancements enabling wearable, insertable, and implantable applications.
- Prolonged contact with medical devices can lead to adverse reactions and biofilm formation, necessitating improved therapeutic strategies.
- Conventional drug-eluting devices offer benefits but lack dynamic control over drug release.
Purpose of the Study:
- To review medical devices with stimuli-responsive drug release capabilities.
- To highlight the potential of smart drug-eluting devices for on-demand and personalized therapies.
- To explore various stimuli that can trigger drug release in medical devices.
Main Methods:
- Review of literature on stimuli-responsive drug delivery from medical devices.
- Categorization of smart drug-eluting devices based on environmental stimuli.
- Analysis of device sensitivity to infection, healing, mechanical, electrical, and chemical triggers.
Main Results:
- Smart drug-eluting medical devices can actively regulate drug release in response to specific environmental changes.
- Stimuli-responsive drug delivery enhances therapeutic performance by enabling precise, on-demand drug release.
- Devices can be designed to respond to infection, healing processes, mechanical forces, electric fields, ultrasound, near-infrared radiation, and chemicals.
Conclusions:
- Endowing medical devices with stimuli-responsiveness is a key step towards personalized medicine.
- These smart devices offer precise, on-demand drug delivery, expanding therapeutic potential and minimizing systemic effects.
- Future research should focus on developing and validating these advanced drug-eluting medical devices for clinical applications.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
In Vitro Drug Release Testing: Overview, Development and Validation
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Inhaled Medications
Energy-releasing Steps of Glycolysis
The first energy-releasing step—the 6th step of glycolysis...
Endocarditis III: Medical Management

